Are patients living with HIV infection at risk for not receiving statin medications for cardiovascular disease risk reduction?

Authors

Nick Hastain, PharmD Candidate, Thomas Jefferson UniversityFollow
Roshni S. Patel, PharmD, BCPS, Thomas Jefferson UniversityFollow
Jason J. Schafer, PharmD, MPH, BCPS, AAHIVP, Thomas Jefferson UniversityFollow

Files

Description

Objective

To determine the prevalence of appropriate statin prescribing for ASCVD risk reduction in PLWH

Publication Date

12-5-2018

Keywords

HIV, ASCVD, statin, cardiovascular disease, atherosclerotic cardiovascular disease

Disciplines

Cardiology | Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Comments

Presented at the 2018 American Society of Hospital Pharmacists (ASHP) Midyear Clinical Meeting

Recommended Citation

Hastain, PharmD Candidate, Nick; Patel, PharmD, BCPS, Roshni S.; and Schafer, PharmD, MPH, BCPS, AAHIVP, Jason J., "Are patients living with HIV infection at risk for not receiving statin medications for cardiovascular disease risk reduction?" (2018). College of Pharmacy Posters. 12.
https://jdc.jefferson.edu/pharmacyposters/12